National Medical Care

Parent W. R. Grace says the firm "is cooperating with FDA and has instituted a comprehensive program to address...concerns" that led the agency to impose an import ban on hemodialysis bloodlines produced at NMC's Reynosa, Mexico facility and hemodialyzers manufactured at its Dublin, Ireland plant. Grace announced on Aug. 5 that the FDA enforcement action "will not affect full year earnings growth from Grace's health care business".